Friday, July 10, 2026

pharma · Metachromatic Leukodystrophy (MLD) · Mucopolysaccharidosis type I, Hurler Syndrome

ORCHARD THERAPEUTICS

News and analysis for ORCHARD THERAPEUTICS on NovaPharmaNews — regulatory, clinical, and market coverage.

London, GB HQ
12 Employees
EMA registrant Type
Company details
Status
Public
HQ
London, GB
Employees
12
Programs
5
Drugs
12
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning ORCHARD THERAPEUTICS — regulatory, clinical, and market coverage.

News and analysis for ORCHARD THERAPEUTICS on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning ORCHARD THERAPEUTICS yet.

Back to company overview →